Phan_2015_J.Pharm.Sci_104_1311

Reference

Title : Immobilised lipase for in vitro lipolysis experiments - Phan_2015_J.Pharm.Sci_104_1311
Author(s) : Phan S , Salentinig S , Hawley A , Boyd BJ
Ref : J Pharm Sci , 104 :1311 , 2015
Abstract :

In vitro lipolysis experiments are used to assess digestion of lipid-based formulations, and probe solubilisation by colloidal phases during digestion. However, proteins and other biological components in the pancreatin often used as the lipase result in high-background scattering when interrogating structures using scattering approaches, complicating the resolution of colloidal structures. In this study, to circumvent this problem, a modified in vitro digestion model employing lipase immobilised on polymer beads, which allows for separation of the lipid digestion components during lipolysis, was investigated. Titration of the fatty acids released during digestion of medium chain triglycerides using pancreatin compared with immobilised lipase, combined with HPLC was used to follow the digestion, and small-angle X-ray scattering was used to determine colloidal structure formation. Digestion of medium chain triglycerides at the same nominal activity revealed that for the immobilised lipase, a longer digestion time was required to achieve the same extent of digestion. However, the same structural endpoint was observed, indicating that structure formation was not affected by the choice of lipase used. Lipolysis with immobilised lipase led to the reduction of parasitic scattering, resulting in clearer and more defined scattering from the structures generated by the lipolysis products. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:1311-1318, 2015.

PubMedSearch : Phan_2015_J.Pharm.Sci_104_1311
PubMedID: 25630824

Related information

Substrate Tricaprin

Citations formats

Phan S, Salentinig S, Hawley A, Boyd BJ (2015)
Immobilised lipase for in vitro lipolysis experiments
J Pharm Sci 104 :1311

Phan S, Salentinig S, Hawley A, Boyd BJ (2015)
J Pharm Sci 104 :1311